|
FY2024
12 months to Dec 31, 2025
|
FY2023
12 months to Dec 31, 2024
|
FY2022
12 months to Dec 31, 2023
|
FY2021
12 months to Dec 31, 2022
|
FY2020
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Amortization | |||||
| Share based compensation expenses | |||||
| Amortization of Debt Issuance Costs and Discounts | |||||
| Changes in accrued interest and exchange rate on short-term and long-term deposits | |||||
| Non-cash impairment, restructuring and other costs | |||||
| Amortization of premium and discount, accrued interest, and other gains (losses) on marketable debt securities, net | |||||
| Remeasurement gain on marketable equity securities and investments in privately held companies | |||||
| Changes in deferred income taxes, net | |||||
| Changes in operating lease right-of-use assets | |||||
| Changes in operating lease liabilities | |||||
| Loss (gain) on foreign exchange, net | |||||
| Decrease (increase) in trade receivables | |||||
| Decrease (increase) in prepaid expenses and other current and long-term assets | |||||
| Increase (decrease) in trade payables | |||||
| Increase (decrease) in employees and payroll accruals | |||||
| Increase in short-term and long-term deferred revenues | |||||
| Increase in accrued expenses and other liabilities | |||||
| Loss from equity method investment | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from short-term and restricted deposits | |||||
| Investment in short-term and restricted deposits | |||||
| Investment in trading marketable debt securities | |||||
| Proceeds from trading marketable debt securities | |||||
| Investment in available-for-sale marketable debt securities | |||||
| Proceeds from available-for-sale marketable debt securities | |||||
| Purchase of property and equipment and lease prepayment | |||||
| Internal-use of software | |||||
| Proceeds from sale of marketable equity securities | |||||
| Investments in privately held companies | |||||
| Payments for businesses acquired, net of acquired cash | |||||
| Proceeds from investments in privately-held companies | |||||
| Investment in other long-term assets | |||||
| Payment for (Proceeds from) Other Investing Activity | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Repayment of convertible notes | |||||
| Purchase of treasury shares | |||||
| Proceeds from issuance of convertible senior notes | |||||
| Payments of debt issuance costs | |||||
| Purchase of 2030 Capped Calls | |||||
| Proceeds from exercise of options and ESPP shares | |||||
| Net cash used in financing activities | |||||
| EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH | |||||
| Increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at the beginning of the year | |||||
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation, Total | |||||
| Supplemental disclosure of cash flow activities: | |||||
| Cash paid during the year for taxes | |||||
| Interest received during the year | |||||
| Supplemental information for non-cash transactions: | |||||
| Right-of-use assets obtained in exchange for operating lease liabilities | |||||
| Non-cash purchase of property and equipment | |||||
| Conversion of convertible notes | |||||
| Restricted Cash and Cash Equivalent | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...